Naltrexone Implant Helps HIV Patients Prevent Opioid Relapse

FRIDAY, April 19, 2019 -- Slow-release implantable naltrexone is associated with better outcomes than the oral drug for HIV-positive patients with an opioid addiction, according to a study published in the April issue of The Lancet HIV. Evgeny...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news